$PRKR
PARKERVISION INC Stock $prkr

$prkr Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000143774923023662 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue	$61.00K	$63.00K	$3.000K
YoY Change	2950.0%	2000.0%
Gross Profit	-$61.00K	-$63.00K	-$3.000K
YoY Change	2950.0%	2000.0%
Gross Profit Margin
Selling, General & Admin	$904.0K	$1.125M	$1.652M
YoY Change	-46.13%	-31.9%	-10.61%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$70.00K	$65.00K	$80.00K
YoY Change	-6.67%	-18.75%	-14.89%
% of Gross Profit
Operating Expenses	$904.0K	$1.125M	$1.652M
YoY Change	-46.13%	-31.9%	-10.61%
Operating Profit	-$965.0K	-$1.188M	-$1.655M
YoY Change	-42.56%	-28.22%	-10.44%
Interest Expense	$107.0K	$107.0K	-$44.00K
YoY Change	12.63%	-343.18%	-156.41%
% of Operating Profit
Other Income/Expense, Net	-$2.958M	$2.621M	-$2.699M
YoY Change	-331.46%	-197.11%	5.51%
Pretax Income	-$3.920M	$1.433M	-$4.398M
YoY Change	875.12%	-132.58%	-0.18%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$3.923M	$1.433M	-$4.398M
YoY Change	875.87%	-132.58%	-0.18%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.05	$0.02	-$0.06
Diluted Earnings Per Share	-$0.05	$0.01	-$56.41K
COMMON SHARES
Basic Shares Outstanding	86.42M	85.18M	77.94M
Diluted Shares Outstanding	86.33M	120.1M	77.97M

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.330M	$4.200M	$846.0K
YoY Change	900.0%	396.45%	-43.11%
Cash & Equivalents	$3.300M	$4.200M	$846.0K
Short-Term Investments
Other Short-Term Assets	$37.00K	$37.00K	$386.0K
YoY Change	164.29%	-90.41%	522.58%
Inventory
Prepaid Expenses	$81.00K	$96.00K
Receivables
Other Receivables
Total Short-Term Assets	$3.451M	$4.333M	$1.232M
YoY Change	446.91%	251.7%	-43.62%
LONG-TERM ASSETS
Property, Plant & Equipment			$6.000K
YoY Change			-83.78%
Goodwill
YoY Change
Intangibles	$1.130M	$1.191M
YoY Change	-24.16%
Long-Term Investments
YoY Change
Other Assets	$3.000K	$6.000K	$20.00K
YoY Change	-83.33%	-70.0%
Total Long-Term Assets	$1.133M	$1.197M	$1.588M
YoY Change	-25.12%	-24.62%	-21.39%
TOTAL ASSETS
Total Short-Term Assets	$3.451M	$4.333M	$1.232M
Total Long-Term Assets	$1.133M	$1.197M	$1.588M
Total Assets	$4.584M	$5.530M	$2.820M
YoY Change	113.81%	96.1%	-32.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$796.0K	$785.0K	$919.0K
YoY Change	-3.86%	-14.58%	62.94%
Accrued Expenses	$580.0K	$578.0K	$651.0K
YoY Change	-16.31%	-11.21%	-15.89%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.180M	$1.751M	$657.0K
YoY Change	56.91%	166.51%	-13.32%
Total Short-Term Liabilities	$2.552M	$3.114M	$2.227M
YoY Change	12.27%	39.83%	6.25%
LONG-TERM LIABILITIES
Long-Term Debt	$11.95M	$10.88M	$9.128M
YoY Change	31.33%	19.14%	-0.98%
Other Long-Term Liabilities	$28.99M	$26.75M	$38.61M
YoY Change	-22.56%	-30.74%	7.74%
Total Long-Term Liabilities	$40.94M	$37.62M	$47.74M
YoY Change	-12.02%	-21.2%	5.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.552M	$3.114M	$2.227M
Total Long-Term Liabilities	$40.94M	$37.62M	$47.74M
Total Liabilities	$43.49M	$40.73M	$49.97M
YoY Change	-10.89%	-18.48%	5.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$432.6M	-$428.7M
YoY Change	-1.21%
Common Stock	$868.0K	$855.0K
YoY Change	10.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$38.91M	-$35.20M	-$47.15M
YoY Change
Total Liabilities & Shareholders Equity	$4.584M	$5.530M	$2.820M
YoY Change	113.81%	96.1%	-32.94%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$3.923M	$1.433M	-$4.398M
YoY Change	875.87%	-132.58%	-0.18%
Depreciation, Depletion And Amortization	$70.00K	$65.00K	$80.00K
YoY Change	-6.67%	-18.75%	-14.89%
Cash From Operating Activities	-$740.0K	-$888.0K	-$737.0K
YoY Change	-0.94%	20.49%	-33.72%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$1.000K	-$4.000K
YoY Change		-125.0%	300.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$1.000K	-$4.000K
YoY Change		-75.0%	300.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-140.0K	-8.971M	1.389M
YoY Change	-159.83%	-745.86%	293.48%
NET CHANGE
Cash From Operating Activities	-740.0K	-888.0K	-737.0K
Cash From Investing Activities	0.000	-1.000K	-4.000K
Cash From Financing Activities	-140.0K	-8.971M	1.389M
Net Change In Cash	-880.0K	-9.860M	648.0K
YoY Change	71.54%	-1621.6%	-185.26%
FREE CASH FLOW
Cash From Operating Activities	-$740.0K	-$888.0K	-$737.0K
Capital Expenditures	$0.00	$1.000K	-$4.000K
Free Cash Flow	-$740.0K	-$889.0K	-$733.0K
YoY Change	-0.94%	21.28%	-34.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	85510000
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	85510000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81246000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81246000
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-22904
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	59-2971472
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4446-1A Hendricks Avenue, Suite 354
	dei	Entity Address City Or Town EntityAddressCityOrTown	Jacksonville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32207
	dei	City Area Code CityAreaCode	904
	dei	Local Phone Number LocalPhoneNumber	732-6100
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	86420431
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4200000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109000	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	96000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	244000	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	37000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	30000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	4333000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	383000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1191000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1359000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9000	usd
CY2023Q2	us-gaap	Assets Assets	5530000	usd
CY2022Q4	us-gaap	Assets Assets	1751000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	785000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	901000	usd
CY2023Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	26000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	23000	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	79000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	79000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	473000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	490000	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	131000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	139000	usd
CY2023Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1620000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	625000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3114000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2257000	usd
CY2023Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	26745000	usd
CY2022Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	40708000	usd
CY2023Q2	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	7050000	usd
CY2022Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	5089000	usd
CY2023Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3418000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3913000	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	407000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	473000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	37620000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	50183000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	40734000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	52440000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	855000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	812000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	392618000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	391724000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-428677000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-443225000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-35204000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-50689000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5530000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1751000	usd
CY2023Q2	us-gaap	Revenues Revenues	0	usd
CY2022Q2	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	25000000	usd
	us-gaap	Revenues Revenues	0	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	63000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	3000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	106000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	-63000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	-3000	usd
	us-gaap	Gross Profit GrossProfit	24894000	usd
	us-gaap	Gross Profit GrossProfit	-6000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1125000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1652000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13210000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3585000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1125000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	1652000	usd
	us-gaap	Operating Expenses OperatingExpenses	13210000	usd
	us-gaap	Operating Expenses OperatingExpenses	3585000	usd
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	0	usd
CY2022Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	28000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	0	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	56000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	107000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	72000	usd
	us-gaap	Interest Expense InterestExpense	213000	usd
	us-gaap	Interest Expense InterestExpense	134000	usd
CY2023Q2	prkr	Gain Loss Contingent Payment Obligation GainLossContingentPaymentObligation	2728000	usd
CY2022Q2	prkr	Gain Loss Contingent Payment Obligation GainLossContingentPaymentObligation	-2699000	usd
	prkr	Gain Loss Contingent Payment Obligation GainLossContingentPaymentObligation	3077000	usd
	prkr	Gain Loss Contingent Payment Obligation GainLossContingentPaymentObligation	-397000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2621000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2743000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2864000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-475000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1433000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-4398000	usd
	us-gaap	Net Income Loss NetIncomeLoss	14548000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4066000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1433000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4398000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14548000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4066000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85263000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77970000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84570000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77763000
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	120061000
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77970000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	119700000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77763000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-36877000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-43553000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-50689000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-44777000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-35204000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-47149000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-35204000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-47149000	usd
	us-gaap	Net Income Loss NetIncomeLoss	14548000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4066000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	131000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	163000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	316000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1491000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3077000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	397000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-41000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-64000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-261000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-213000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	48000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	210000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-81000	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-2282000	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	2457000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12266000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1609000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4000	usd
	prkr	Proceeds Payments From Issuance Of Common Stock Including Contingent Payment Rights ProceedsPaymentsFromIssuanceOfCommonStockIncludingContingentPaymentRights	121000	usd
	prkr	Proceeds Payments From Issuance Of Common Stock Including Contingent Payment Rights ProceedsPaymentsFromIssuanceOfCommonStockIncludingContingentPaymentRights	-18000	usd
	prkr	Proceeds From Warrant And Stock Option Exercised ProceedsFromWarrantAndStockOptionExercised	4000	usd
	prkr	Proceeds From Warrant And Stock Option Exercised ProceedsFromWarrantAndStockOptionExercised	83000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8174000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1429000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4091000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-184000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	109000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1030000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4200000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	846000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"><b><em style="font: inherit;">1.</em> Description of Business</b></p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">ParkerVision, Inc. and its wholly-owned German subsidiary, ParkerVision GmbH (collectively “ParkerVision”, “we” or the “Company”), is in the business of innovating fundamental wireless hardware technologies and products.</p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">We have designed and developed proprietary radio frequency (“RF”) technologies and integrated circuits based on those technologies, and we license those technologies to others for use in wireless communication products. We have expended significant financial and other resources to research and develop our RF technologies and to obtain patent protection for those technologies in the United States of America (“U.S.”) and certain foreign jurisdictions. We believe certain patents protecting our proprietary technologies have been broadly infringed by others, and therefore the primary focus of our business plan is the enforcement of our intellectual property rights through patent licensing and infringement litigation efforts. We currently have patent enforcement actions ongoing in various U.S. district courts against mobile handset, smart television and other WiFi product providers, as well as semiconductor suppliers, for the infringement of a number of our RF patents. We have made significant investments in developing and protecting our technologies.</p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p>
	us-gaap	Net Income Loss NetIncomeLoss	14500000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12300000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	70000.00	usd
	prkr	Proceeds From Issuance Of Debt And Equity ProceedsFromIssuanceOfDebtAndEquity	800000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4200000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-428700000	usd
	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"><b><em style="font: inherit;">3.</em> Basis of Presentation </b></p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The accompanying unaudited condensed consolidated financial statements for the period ended <em style="font: inherit;"> June 30, 2023</em> were prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form <em style="font: inherit;">10</em>-Q and Rule <em style="font: inherit;">10</em>-<em style="font: inherit;">01</em> of Regulation S-<em style="font: inherit;">X.</em> Operating results for the <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> June 30, 2023</em>, are <em style="font: inherit;">not</em> necessarily indicative of the results that <em style="font: inherit;"> may </em>be expected for the year ending <em style="font: inherit;"> December 31, 2023</em>, or future years. All normal and recurring adjustments which, in the opinion of management, are necessary for a fair statement of the consolidated financial condition and results of operations have been included.</p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The year-end condensed consolidated balance sheet data was derived from audited financial statements for the year ended <em style="font: inherit;"> December 31, 2022</em>. Certain information and disclosures normally included in the notes to the annual financial statements prepared in accordance with GAAP have been omitted from these interim condensed consolidated financial statements. These interim condensed consolidated financial statements should be read in conjunction with our latest Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> December 31, 2022</em> (“<em style="font: inherit;">2022</em> Annual Report”). Certain reclassifications have been made to prior period amounts to conform to the current period presentation.</p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The condensed consolidated financial statements include the accounts of ParkerVision, Inc. and its wholly-owned German subsidiary, ParkerVision GmbH, after elimination of all intercompany transactions and accounts. </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt; text-indent: -18pt;"> </p>
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	25000000.0	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1433000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-4398000	usd
	us-gaap	Net Income Loss NetIncomeLoss	14548000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4066000	usd
CY2023Q2	prkr	Income Attributable To The Dilutive Securities If Converted Or Exercised IncomeAttributableToTheDilutiveSecuritiesIfConvertedOrExercised	102000	usd
CY2022Q2	prkr	Income Attributable To The Dilutive Securities If Converted Or Exercised IncomeAttributableToTheDilutiveSecuritiesIfConvertedOrExercised	0	usd
	prkr	Income Attributable To The Dilutive Securities If Converted Or Exercised IncomeAttributableToTheDilutiveSecuritiesIfConvertedOrExercised	202000	usd
	prkr	Income Attributable To The Dilutive Securities If Converted Or Exercised IncomeAttributableToTheDilutiveSecuritiesIfConvertedOrExercised	0	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	1535000	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-4398000	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	14750000	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-4066000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85263000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77970000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84570000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77763000
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	34798000
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	35130000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	120061000
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77970000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	119700000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77763000
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	35880000
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	63829000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	24865000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	63829000
CY2023Q2	prkr	Prepaid Services PrepaidServices	46000	usd
CY2022Q4	prkr	Prepaid Services PrepaidServices	202000	usd
CY2023Q2	us-gaap	Prepaid Insurance PrepaidInsurance	25000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	25000	usd
CY2023Q2	prkr	Prepaid Licenses Software Tools And Support PrepaidLicensesSoftwareToolsAndSupport	23000	usd
CY2022Q4	prkr	Prepaid Licenses Software Tools And Support PrepaidLicensesSoftwareToolsAndSupport	15000	usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2000	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	96000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	244000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10517000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14319000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9326000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12960000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1191000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1359000	usd
CY2023Q2	us-gaap	Convertible Debt ConvertibleDebt	5038000	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	4538000	usd
CY2023Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1620000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	625000	usd
CY2023Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3418000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3913000	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10300000
	prkr	Class Of Warrant Or Right Weighted Average Remaining Life ClassOfWarrantOrRightWeightedAverageRemainingLife	P1Y7M6D
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	300000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1500000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	200000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure

Files In Submission

Name	View Source	Status
prkr-20230630_lab.xml	Edgar Link	unprocessable
0001437749-23-023662-index-headers.html	Edgar Link	pending
0001437749-23-023662-index.html	Edgar Link	pending
0001437749-23-023662.txt	Edgar Link	pending
0001437749-23-023662-xbrl.zip	Edgar Link	pending
ex_526255.htm	Edgar Link	pending
ex_526256.htm	Edgar Link	pending
ex_526257.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prkr-20230630.xsd	Edgar Link	pending
prkr20230630_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
prkr-20230630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
prkr-20230630_def.xml	Edgar Link	unprocessable
prkr-20230630_pre.xml	Edgar Link	unprocessable
prkr20230630_10q_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRKR
PARKERVISION INC Stock $prkr

2023 Q3 Form 10-Q Financial Statement

#000143774923023662 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRKR PARKERVISION INC Stock $prkr

2023 Q3 Form 10-Q Financial Statement

#000143774923023662 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRKR
PARKERVISION INC Stock $prkr